T 1128/19 (Bispecific Single Chain Antibody/AMGEN) of 10.03.2023

European Case Law Identifier: ECLI:EP:BA:2023:T112819.20230310
Date of decision: 10 March 2023
Case number: T 1128/19
Petition for review of: -
Application number: 16167900.6
IPC class: A61K 39/00 C07K 16/28 C07K 16/40 C07K 16/30 C07K 16/22
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: Abstract on EPC2000 Art 125
Application title: Cross-Species-Specific PSMAXCD3 Bispecific Single Chain Antibody
Applicant name: Amgen Research (Munich) GmbH
Opponent name: -
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 125 European Patent Convention Art 84 European Patent Convention Art 97(2)Rules of procedure of the Boards of Appeal Art 12(4)
Keywords: Divisional application - double patenting (yes)
Claims - clarity
Claims - auxiliary request 4 (no)
Catchword: -
Cited cases: G 0004/19
Citing cases: -

Order

For these reasons it is decided that:

The appeal is dismissed.

The appeal fee is to be reimbursed at 25%.